New trends in transplantation: the use of Thymoglobulin^®

Bibliography

• Ballen KK, King RJ, Chitphakdithai P, et al. The National Marrow Donor Program Experience: the first 20 years of unrelated donor stem cell transplantation. Biol Blood Marrow Transplant 2008;14:2-7
   PubMedGoogle Scholar
• Sierra J, Storer B, Hansen JA, et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplant 2000;26:397
   PubMed Web of Science ®Google Scholar
• Ruzek M, Dzuris J, Gao L, et al. Selected mechanistic studies and future directions for thymoglobulin. Transplantation 2007;84:S27-34
   PubMedGoogle Scholar
• Revillard JP. Immunopharmacology of thymoglobulin. Graft 1999;2:S6
   Google Scholar
• Brayman K. New insights in to the mechanisms of action of thymoglobulin. Transplantation 2007;84:S3-4
   Google Scholar
• Michallet MC, Preville X, Flacher M, et al. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 2003;75:657
   PubMed Web of Science ®Google Scholar
• Chappell D, Beiras-Fernandez A, Hammer C, et al. In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model. Transplantation 2006;81:552-8
   PubMed Web of Science ®Google Scholar
• Beiras-Fernandez A, Thein E, Chappel D, et al. Polyclonal anti-thymocyte globulins influence apoptosis in reperfused tissues after ischemia in a non-human primate model. Transpl Int 2004;17:453-7
   PubMed Web of Science ®Google Scholar
• Zand MS, Vo T, Pellegrin T, et al. Apoptosis and complement mediated lysis of myeloma cells by polyclonal rabbit anti-thymocyte globulin. Blood 2006;107:2895
   PubMed Web of Science ®Google Scholar
• Lopez M, Clarkson MR, Albin M, et al. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 2006;17:2844
   PubMed Web of Science ®Google Scholar
• Lowsky R. Thymoglobulin and regulatory T cells in organ and hematopoietic cell transplantation. Transplantation 2007;84:S20-6
   PubMedGoogle Scholar
• Waller EK, Langston AA, Lonial S, et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of HLA-matched blood hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 2003;9:460-71
   PubMed Web of Science ®Google Scholar
• Hale GA, Call SK, Handgretinger R, et al. Rabbit anti-thymocyte globlulin pharmacokinetics in pediatric patients receiving a hematopoietic stem cell transplant [abstract]. Biol Blood Marrow Transplant 2006;12, 503 a (abstract)
   Google Scholar
• Seidel MG, Fritsch G, Matthes-Martin S, et al. Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2005;27:532-6
   PubMed Web of Science ®Google Scholar
• Regan JF, Lyonnais C, Campbell K, et al. Total and active thymoglobulin levels: effect of dose and sensitization on serum concentration. Transpl Immunol 2001;9:29-36
   PubMed Web of Science ®Google Scholar
• Goggins WC, Pascual MA, Powelson JA, et al. A prospective, randomized clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003;76:798-802
   PubMed Web of Science ®Google Scholar
• Soulillou JP, Cantarovich D, Le Mauff B, et al. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990;322:1175-82
   PubMed Web of Science ®Google Scholar
• Hardinger KL, Schnitzler MA, Miller B, et al. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation 2004;78:136-41
   PubMed Web of Science ®Google Scholar
• Hardinger KL, Schnitzler MA, Koch MJ, et al. Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience. Transplantation 2006;81:1285-89
   PubMed Web of Science ®Google Scholar
• Agha IA, Irfan A, Rueda J, et al. Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation 2002;73:473-5
   PubMed Web of Science ®Google Scholar
• Patel SJ, Duhart BT, Krauss AG, et al. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction. Transplantation 2008;86:313-20
   PubMed Web of Science ®Google Scholar
• Hardinger KL, Rhee S, Buchanan P, et al. A prospective, randomized, double-blinded comparison of thymoglobulin versus ATGam for induction immunosuppressive therapy: 10-year results. Transplantation 2008;86:947-52
   PubMed Web of Science ®Google Scholar
• Mehrabi A, Mood ZA, Sadeghi M, et al. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant 2007;22(Suppl 8):54-60
   Google Scholar
• Soliman T, Hetz H, Burghuber C, et al. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. Liver Transpl 2007;13:1039-64
   PubMed Web of Science ®Google Scholar
• McCurry KR, Iacono A, Zeevi A, et al. Early outcomes in human lung transplantation with thymoglobulin or campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg 2005;130:528-37
   PubMed Web of Science ®Google Scholar
• Tanchanco R, Krishnamurthi V, Winans C, et al. Beneficial outcomes of a steroid-free regimen with thymoglobulin induction in pancreas-kidney transplantation. Transplant Proc 2008;40:1551-56
   PubMed Web of Science ®Google Scholar
• Nozynski J, Zakliczynski M, Zembala-Nozynska E, et al. Thymoglobulin administered early after heart transplantation reduces early myocardial hypertrophy assessed by morphometric studies. Transplant Proc 2007;39:2825-32
   PubMed Web of Science ®Google Scholar
• Basara N, Baurmann H, Kolbe K, et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant 2005;35:1011-8
   PubMed Web of Science ®Google Scholar
• Duggan P, Booth K, Chaudhry A, et al. Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis. Bone Marrow Transplant 2002;30:681-86
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Camparelli T, Barisione G, et al. Thymoglobulin prevents chronic graft versus host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006;12:560-5
   PubMed Web of Science ®Google Scholar
• Deeg HJ, Storer BE, Boeckh M, et al. Reduced incidence of acute and chronic graft versus host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen. Biol Blood Marrow Transplant 2006;12:573-8
   PubMed Web of Science ®Google Scholar
• Ballen KK, Spitzer TR, Yeap BY, et al. Double unrelated reduced intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007;13:82-9
   PubMed Web of Science ®Google Scholar
• Ciesca P, Dirlando M, Park SI, et al. Thymoglobulin and rate of infectious complications after transplantation. Transplant Proc 2007;39:463-64
   PubMed Web of Science ®Google Scholar
• Ballen KK, Cutler C, Yeap BY, et al. High rate of second malignancies after reduced intensity double cord blood transplants in adults [abstract]. Blood 2008;112:1958a
   Google Scholar
• Nash RA, Dansey R, Storek J, et al. Epstein–Barr virus associated posttransplantation lymphoproliferative disorders after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. Biol Blood Marrow Transplant 2003;9:583-91
   PubMed Web of Science ®Google Scholar
• Brennan DC, Flavin K, Lowell JA, et al. A randomized, double-blinded comparison of thymoglobulin versus ATGam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 1999;67:1011
   PubMed Web of Science ®Google Scholar
• Barker JN, Weisdorf DJ, DeFor TE, et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003;102:1915-9
   PubMed Web of Science ®Google Scholar